Precision Vaginal Microbiome Transplantation in Women With Bacterial Vaginosis

Launched by ZHUJIANG HOSPITAL · Feb 8, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at a new treatment for women with bacterial vaginosis, a common condition where the balance of bacteria in the vagina is disrupted. The researchers want to see if a procedure called vaginal microbiome transplantation, which uses healthy bacteria from other women, specifically Lactobacillus cispatus, can help treat this condition effectively and safely.

To participate in the trial, women need to be between 18 and 55 years old, have a history of sexual behavior, and have been diagnosed with bacterial vaginosis. However, women who are pregnant, recently gave birth, or have certain health issues like autoimmune diseases or cancer are not eligible. If chosen for the study, participants can expect to receive the new treatment and will be monitored for how well it works and if there are any side effects. This trial is currently looking for volunteers, so if you fit the criteria and are interested, it could be a great opportunity to help advance treatment options for bacterial vaginosis.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • 1. History of sexual behaviour 2.18-55 years old 3. Women were diagnosed as bacterial vaginosis
• Exclusion Criteria:
• • 1. During pregnancy, or within 8 weeks after delivery;
• • 2. presence of systemic diseases (such as SLE, malignant tumors, etc.)